Combination Docetaxel/ Vinorelbine for Metastatic Breast Cancer and Non-Small-Cell Lung Cancer

ONCOLOGY

Volumn 11, Issue 8 SUPPL., 1997, Pages 44-47

  Aapro, Matti S ^a,b  

^a Masaryk Oncologic Institute   (Czech Republic)

^b CLINIQUE DE GENOLIER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; NAVELBINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DOSE RESPONSE; DRUG POTENTIATION; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; THROMBOSIS;

EID: 0030847187     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Diaz JF, Andreu JM: Assembly of purified GDP-tubulin into microtubules induced by Taxol and Taxotere: Reversibility, ligand stoichiometry, and competition. Biochemistry 32-2747, 1993.
2. Gueritte-Voegelein F, Guenard D, Lavelle F, et al: Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 34:992-998, 1991.
3. Ringel I, Horwitz SB: Studies with RP 56976 (Taxotere): A semisynthetic analogue of taxol. J Natl Cancer Inst 83:288-291, 1991.
4. Burris HA, Fields S: Summary of data from in vitro and phase I vinorelbine (Navelbine) studies. Semin Oncol 21(suppl 10): 14-21, 1994
5. Binet S, Fellows A, Mcininger V: In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence. Semin Oncol 16(suppl 4):5-8, 1989.
6. Lavelle F, Bissery MC, Combeau C, et al: Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 22(suppl 4):3-16, 1995.
7. Riou J-F, Petitgenet O, et al Cellular uptake and efflux of docetaxel (Taxotere) and paclitaxel (Taxol) in P388 cell line (abstract 2292). Proc Am Assoc Cancer Res 35:385, 1994
8. Binet S, Chineau E, Fellows A, et al: Immunofluorescence of the action of Navelbine, vincristine, and vinblastine on mitotic and axonal microtubules. Int J Cancer 46:262-266, 1990.
9. Bissery MC, Azli N, Fumoleau P: Docetaxel in combination with vinorelbine: Preclinical-clinical correlation (abstract 1550). Proc Am Soc Clin Oncol 15:487, 1996.
10. Fumoleau P, Delecroix V, Perrocheau G, et al: Final results of a phase I dose finding and pharmacokinetic study of docetaxel in combination with vinorelbine in metastatic breast cancer (abstract 606P). Ann Oncol 7(suppl 5): 126, 1996
11. Douillard JY, Monnier A, Le Chevalier, et al: Docetaxel in combination with vinorelbine in chemotherapy naive patients with metastatic or unresectable non-small-cell lung cancer (NSCLC): Preliminary results of a phase 1 study (abstract). Proc Am Soc Clin Oncol 16, 1997.
12. Early E, Miller, VA. Grant SC, et al: Phase I/II trial of docetaxel and vinorelbine with filgrastim (G-CSF) in patients with advanced non-small cell lung cancer (abstract 1678). Proc Am Soc Clin Oncol 16, 1997.
13. Schiller JH, Larson M, et al: Phase I trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy (abstract 1733). Proc Am Soc Clin Oncol 16, 1997.
14. Trillet-Lenoir V, Monnier A, Douillard JY, et al: Interim results of a phase II study of docetaxel (Taxotere) and vinorelbine in chemotherapy naive patients with advanced non-small-cell lung carcinoma (NSCLC) (abstract 450P). Ann Oncol 7(suppl 5):95, 1996
15. Kourousis C, Androullakis N, Kakolyris S, et al: First line treatment of non-small-cell lung carcinoma (NSCLC) with docetaxel and vinorelbine: A phase II study(abstract 1441P). Ann Oncol 7(suppl 5):93, 1996